Chipscreen’s Epidaza Patent Faces Invalidation Request Review
China-based Shenzhen Chipscreen Biosciences Co., Ltd (SHA: 688321) has announced that a patent invalidation request...
Biogen Proposes to Acquire Sage Therapeutics for $469M
US-based Sage Therapeutics, Inc. (NASDAQ: SAGE) has announced that it received an unsolicited, nonbinding proposal...
Medtronic Secures Exclusive Distribution Rights for Contego’s Neuroguard and Excipio
US-Irish firm Medtronic (NYSE: MDT) has entered into an exclusive distribution agreement with Contego Medical,...
Eli Lilly to Acquire Scorpion Therapeutics’ STX-478 for $2.5B
US-based pharmaceutical giant Eli Lilly and Company (NYSE: LLY) is set to acquire STX-478 from...
Johnson & Johnson to Acquire Intra-Cellular Therapies for $14.6B
US-based Johnson & Johnson (J&J, NYSE: JNJ) is set to acquire all outstanding shares of...
GSK Acquires IDRx for $1B to Boost GIST Treatment Pipeline
UK-headquartered GlaxoSmithKline (GSK; NYSE: GSK) has entered into an agreement with US-based biopharma IDRx, Inc....
Autobio Diagnostics Partners with Boditech Med for Korean IVD Market
China-based Autobio Diagnostics Co., Ltd (SHA: 603658) has announced a strategic partnership with South Korea-headquartered...
Henlius and Abbott Sign License Agreement for Biosimilars and Biologic Drug
China-based Shanghai Henlius Biotech Inc. (HKG: 2696) has announced a strategic license agreement with Abbott...
Chongqing Genrix’s Silevimig NDA Accepted for Rabies Immunization Review
China-based Chongqing Genrix Bio Pharmaceutical Co., Ltd. (SHA: 688443) has announced that a New Drug...
Novartis to Defend Entresto Patent After CAFC Ruling
Novartis (NYSE: NVS) has revealed a favorable decision by the US Court of Appeals for...
Bristol-Myers Squibb Exercises License for ArsenalBio’s AB-4000 Series
US-based cell therapy company Arsenal Biosciences, Inc. has announced that Bristol-Myers Squibb (BMS, NYSE: BMY)...
Hengrui and Kailera Announce Positive Phase II Results for HRS9531 in Weight Loss
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) and its US partner Kailera Therapeutics, Inc....
Gentize Biopharma Raises $13.64M in Pre-Series A for Vaccine Development
Gentize Biopharma, a clinical-stage vaccine developer based in Nanjing, has reportedly raised close to RMB...
Roche’s VENTANA Kappa and Lambda Dual ISH Test Gains FDA Clearance
Swiss pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) has announced that it has received marketing...
Illumina Partners with NVIDIA to Advance Multiomic Data Analysis
US-based genomics giant Illumina (NASDAQ: ILMN) has announced a strategic partnership with chip manufacturer NVIDIA...
Leqembi Autoinjector Advances with FDA Review for Alzheimer’s Treatment
Partners Eisai Co., Ltd (TYO: 4523) and Biogen Inc. (NASDAQ: BIIB) have announced that the...
Mediar Therapeutics and Eli Lilly Ink Deal for IPF Drug MTX-463
US-based clinical-stage biotech Mediar Therapeutics, Inc. has announced a global license agreement with Eli Lilly...
Cornerstone Robotics Raises $68.2M in Series C to Advance Surgical Robots
Cornerstone Robotics, an innovative surgical robot developer based in Shenzhen, has reportedly raised over RMB...
MGI Tech’s DNBSEQ-E25 Receives NMPA License as World’s First Self-Luminescent Sequencer
China-based gene sequencing specialist MGI Tech Co., Ltd has announced that it has received a...
Medtronic’s BrainSense Technologies Win EU, UK CE Mark for Parkinson’s Treatment
US-Irish firm Medtronic (NYSE: MDT) has announced that it has received CE (Conformité Européenne) Mark...